Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01845792
Title Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

prostate adenocarcinoma

Therapies

Cabazitaxel

Abiraterone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.